Knowledge of Cervical Cancer Among Females
. J. Annama. Comprehensive Text Book of Midwifery and Gynaecological Nursing. 3rd Edn., Japyee Publisher, 733–73p.
. Ferlayj, H.R. Shin, F. Bray, D. Formand, Mathersc, D.M. Parkin. GLOBOCAN2008,Cancer incidence and mortality worldwide.
. IARC cancer base No.10.Lyon, France International Agency for research On cancer, 2010.
. S.J. Goldie, D. Grima, M. Kohli, T.C. Wright, M. Weinstein, E. Franco. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV/18 vaccine, Int J. 2003; 106: 896–904p.
. Int J Sci Res (IJSR ISS N(Online); 2319-7064 Volume issue3,March 2014.
. Progress in cervical cancer prevention, The CCA report card south Africa AUGUST 2011.
. T. Singhal. Indian Academy of pediatrics committee on immunization (IAPCOI)-Consensus Recommendations Immunization 2008, Indian Pediatr. 2008; 45: 635–48p. [Pub Med] 65.
. D.M. Harper. prophylactic humanpapiloma virus vaccines to prevent cervical cancer: review of the phase 2 and 3rd trial, Therapy. 2008; 5: 313–24p.
. M. Shally, S. Sanju. Text Book of Midwifery and Obstetrics. 3rd Edn., Lotus Publisher; 2013, 555–8p.
A. NandakumarA’Ramnath, M. Chaturvedi. The magnitude of cancer cervix in India, Indian J Med Res. 2009; 130: 219–28p.
. S.T. Linda, C. Tomori, T. Lyons, L. Langseth, Cl. Bennett, Gariciap. Cervical cancer prevention knowledge, Am J Obstet Gynecol. 2002; 186(5): 938–43p.
. Progress in cervical cancer prevention: the CCA Report card South Africa AUGUST 2011 Villa LL, Costa RL, Petta (A, Android RP,Ault K A, Giuliano AR, et al prophylactic quadrivalent human papillomavirus (types 6,11,16and 18) LI Virus like partical vaccine in young women: a randomized double-blind placebo-controlled multicentre phase 11 efficacy trial, Lancet Oncol. 2005; 6: 271–8p.
- There are currently no refbacks.